Advancing
cell therapy.
Biruni Cell Therapy and Thermo Fisher Scientific signed a collaboration agreement in London to help build Türkiye’s advanced cell therapy ecosystem.
Beyond equipment.
The collaboration reaches beyond the supply of technologies. The teams intend to develop the manufacturing, analytical and quality capabilities needed for advanced cell therapies in Türkiye.
Areas of collaboration
- Co-develop manufacturing and analytical protocols for advanced cell therapies.
- Jointly validate critical manufacturing processes and quality systems.
- Optimise and upgrade cell therapy manufacturing technologies to better meet GMP and clinical requirements.
- Develop viral vector and supporting laboratory workflows.
- Establish scalable operational pipelines to accelerate technology transfer and manufacturing readiness.
The aim is a sustainable platform that improves through scientific collaboration and shared expertise, supporting Türkiye’s ambition to become a regional hub for advanced therapies.
Dr Muhammet Avcil and Claire Wallace at the signing of the collaboration agreement between Biruni Cell Therapy and Thermo Fisher Scientific.
Biruni Cell Therapy thanks Claire Wallace and Suzanne Holden for their trust and collaboration as the teams work to translate this agreement into meaningful scientific and clinical impact.
← Back to News